HDAC9 and cancer: Importantly, the HDAC inhibitor, MS-275 is effective in inhibiting the proliferation of cancer cells (Daoy and D283) in vitro through MS-275-induced increase in acetylation of histones H3 and H4 in the DR4 promoter and reactivation of DR4 expression in cancer cells.